FDA Inspection 1313132 — Massachusetts General Hospital Fertility Center
The FDA completed an inspection of Massachusetts General Hospital Fertility Center on April 3, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 3, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Boston, MA (United States)